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Abstract
Irreproducibility of research causes a major concern in academia. This concern
affects all study designs regardless of scientific fields. Without testing the
reproducibility and replicability it is almost impossible to repeat the research and
to gain the same or similar results. In addition, irreproducibility limits the
translation of research findings into practice where the same results are expected.
To find the solutions, the Interacademy Partnership for Health gathered
academics from established networks of science, medicine and engineering
around a table to introduce seven strategies that can enhance the reproducibility:
pre-registration, open methods, open data, collaboration, automation, reporting
guidelines, and post-publication reviews. The current editorial discusses the
generalisability and practicality of these strategies to systematic reviews and
claims that systematic reviews have even a greater potential than other research
designs to lead the movement toward the reproducibility of research. Moreover, I
discuss the potential of reproducibility, on the other hand, to upgrade the
systematic review from review to research. Furthermore, there are references to
the successful and ongoing practices from collaborative efforts around the world
to encourage the systematic reviewers, the journal editors and publishers, the
organizations linked to evidence synthesis, and the funders and policy makers to
facilitate this movement and to gain the public trust in research.
Key words: Systematic review; Meta-analysis; Reproducibility of results; Automation;
Data science; Data anonymization; Datasets; Guideline adherence; Guideline; Peer-
review
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: Reproducibility increases the practicality of the research findings and gains the
public trust in research. The ongoing developments in automation of systematic reviews,
availability of pre-registration platform, dealing more with secondary data or
anonymized primary data, the collaboration culture among the organizations who
produce systematic reviews, and finally having an update step that mandates replicability
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are all reasons that systematic reviews have the potential to lead the movement toward
the reproducibility among the other research designs. Meanwhile, reproducibility can
help the systematic reviews to be considered as research design rather than literature
review.
Citation: Shokraneh F. Reproducibility and replicability of systematic reviews. World J Meta-
Anal 2019; 7(3): 66-71
URL: https://www.wjgnet.com/2308-3840/full/v7/i3/66.htm
DOI: https://dx.doi.org/10.13105/wjma.v7.i3.66
INTRODUCTION
Systematic  reviews are at  high levels  of  evidence hierarchy in clinical  practice[1].
People who are involved in healthcare systems usually use systematic reviews in
research,  policy,  and  practice[3]  trusting  the  reproducibility  of  the  results  when
implemented[2].  At  the same time,  some criticize  that  the systematic  reviews are
literature reviews not research[4,5]. To utilize the systematic reviews in practice and to
call  them research studies,  we need reproducibility testing;  and to ensure that  a
systematic review is reproducible it is important to design, to record and to report
systematic reviews in a transparent and reproducible way and to prioritize and fund
reproducible reviews[6]. Some suggest that a team independent from the original team
can repeat the systematic reviews to ensure the reproducibility[7]. Since conducting
systematic reviews is already time-consuming[8] and resource-rating[9], it is arguable
how adding more steps such as reproducibility test  that requires more time and
resources could reduce waste and increase value.
In context of this paper, reproducibility is re-conducting the same study, using the
same methods and data by a different researcher or team and the replicability is re-
doing the same study to gather new data or recollect the data[10].
To provide solutions for irreproducibility, the Interacademy Partnership for Health
introduced seven strategy to enhance the reproducibility practice in science[11]. This
editorial discusses the progress with using these strategies in systematic reviewing
process  and  calls  for  collaboration  in  all  levels  of  system  to  enhance  the
reproducibility of systematic reviews.
STRATEGY 1: PRE-REGISTRATION
Currently, prospective registration of systematic review protocols in PROSPERO, a
register of systematic review protocols, is recommended[12]. Compared to clinical trials
with at least 17 registries[13] there is only one register for systematic reviews; however,
unlike  clinical  trials,  it  is  not  yet  mandatory  to  register  systematic  reviews
prospectively[14]. Today, PROSPERO covers only 30000 records of conducted, ongoing,
awaiting,  and  abandoned review family  (less  than  a  third  of  100000  systematic
reviews in MEDLINE)[15], it does not support the quality control mechanism[16], and it
lacks a rigor follow-up procedure for abandoned systematic reviews[17]. To look at the
bright side, there is an association between registration of the published reviews and
the quality of these reviews[18]. Allocating more resources to this register, training and
encouraging the systematic reviewers to register their reviews, and making the pre-
registration a standard for bias control will push the reproducibility theory toward
practice.
STRATEGY 2: OPEN METHODS
Researchers should share search strategies for all databases[19] and analytical codes for
meta-analysis[20]  as  part  of  the  methods  of  systematic  reviews.  Following to  the
prospective registration and publication of  the protocol,  the researchers and the
research audiences could assess the reproducibility and detect if any variation from
the protocol could have important implementation messages for research, policy and
practice[12].  This practice is not just to test the reproducibility but also to replicate
another analysis or a new update for the systematic review. None of these are possible
WJMA https://www.wjgnet.com March 31, 2019 Volume 7 Issue 3
Shokraneh F. Reproducibility and replicability of systematic reviews
67
without access to all search strategies and statistical codes for meta-analysis.
STRATEGY 3: OPEN DATA
Search results (excluding copyrighted abstract and database-specific meta-data) in
Research Information Systems (RIS) format[21] and extracted data and meta-data from
the studies are the main resulting dataset during the systematic reviewing[22-24]. Access
to open data from systematic reviews makes it possible to re-screen the search results,
to de-duplicate the update searches,  to re-run the meta-analyses,  and to test  the
reproducibility of searching, screening, and data analysis steps. Besides, these data
will  have more value if  they have been shared beside their associated meta-data
following FAIR guidelines (findable, accessible, inter-operable, and reusable)[25]. There
have already been calls for sharing the data from systematic reviews but there is no
policy or action in place[22-24]. Sharing the data from all systematic reviews can lead
into data-driven innovations with potential for knowledge discovery and saving the
waste of resources and lives.
STRATEGY 4: COLLABORATION
Collaboration among research teams in small or large scale increases the chance for
more expertise  input  and enhances the error  detection and fixation practice[26,27].
Sharing the data among collaborators  or  interested research groups could bring
together the data and resources for re-analyzing the same data[20] or innovations[23] that
are impossible without such collaboration. It is not good practice to hold the data for
years hoping to receive funding or innovating while sharing could result in faster
innovation, receiving credits or collaboration in grant applications[26,27]. It also raises
the morality and mortality question that is it ethical to hold the data when sharing it
could lead to decisions that can save public resources and lives, and reduce the waste.
The data extracted from other primary research for systematic reviews cannot be
owned by the systematic reviewers or organizations that produce the systematic
reviews.
STRATEGY 5: AUTOMATION
International  Collaboration for  the Automation of  Systematic  Reviews produces
annual report of progress for automation of systematic reviews[28-30]. This collaboration
seems to understand well that the automation is a key for reproducibility and follows
Vienna Principles that also emphasize on the replicability of automation activities and
sharing the program codes for  wider  use by the community[28].  The value of  the
automation becomes more obvious looking at reports of human errors in systematic
reviews in searching[31] and data extraction steps[32]. The service provided by machine
can  speed  the  process  and  reduce  the  waste  caused  by  human  errors  through
standardization of practices such as statistical analysis or systematic review write-up
steps[30,33].  Despite  all  technological  development,  systematic  reviewers  have
underused the automation tools[34]. Currently, Systematic Review Data Repository[35],
EPPI-Reviewer[36], Study-Based Registers[37], and Evidence Pipeline as semi-automated
systems have the potential to evolve into automated systems for systematic reviews.
STRATEGY 6: REPORTING GUIDELINES
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)[38]
now celebrates a decade of being used in reporting step of systematic reviews and
major  journals  enforce  the  systematic  reviewers  to  follow  the  PRISMA  family
guidelines in reporting. Such reporting guidelines are helping researchers to report
certain items for publications and it is not their primary purpose to advocate the
reproducibility[6]. There is an update of PRISMA 2019 in progress that will include
more items and some these items can maximize the reproducibility practice[6].
STRATEGY 7: POST-PUBLICATION REVIEW
Pre-publication peer-reviews are  limited to  a  few people  while  post-publication
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reviews give chance for wider audience to appraise and comment on some aspect of
the research. Post-publication activities take many forms including letter to editor,
commentary, blogs, and other social media posts[26]. These reviews are separate and
independent from the original research and the only connection is through a link or
citation. As a result, it is hardly possible to find all these reviews integrated in one
place. This problem expands when there are retractions to the original systematic
reviews or the findings are published in salami of papers.  Such post-publication
reviews, however, are encouraged in particular for systematic reviews because they
can be taken into account in the next updates of the current systematic review. Having
an  update  step  in  development  of  systematic  reviews,  unlike  other  published
literature, is a unique advantage of systematic reviews allowing the reviewers to
correct their mistakes and errors or to consider addition of new data or aspect to the
review.
OPEN PROCESS: EMBEDDED REPRODUCIBILITY IN
AGREEMENT CHECKS
As an addition to these strategies, it is also important not to overlook the process of
the systematic reviewing and its connection to reproducibility. The routine practice in
systematic  reviews  is  to  involve  at  least  two  researchers  in  screening  and  data
extraction steps to reduce human errors[32,39] through double-checking of the decision
and to reach an agreement. Such agreement sometimes requires a discussion between
two reviewers or inviting the comments from another usually senior researcher. It
means the decision on eligibility of studies or accuracy of data extraction is being
replicated twice or three times. Since this process itself is replicating part of the review
and has value for improving the reproducibility, some of the automation and semi-
automation systems allow the researchers to document the process of double- and
triple-checking within the system but for transparency purposes, this needs to be
shared  as  well.  In  other  words,  the  process  should  be  documented  and  shared
publicly.
SYSTEMATIC REVIEWS AS ROLE MODEL FOR OTHER
RESEARCH DESIGNS
Systematic reviews have the great potential to lead the reproducibility practice among
the rest of study designs in scientific fields because: A. Having an update step allows
the systematic reviews to be corrected and helps in advancing ‘living systematic
reviews’; B. Making a unique progress in automation of systematic reviews helps
researchers  to save time and resources in every step of  systematic  reviewing;  C.
Provision of protocol and methods facilitates the replication of systematic review in
update step. To make such role model, the organizations whose main activity includes
producing systematic reviews should come together and collaborate on developing
policies  on  reproducibility  and  sharing  the  data  and  methods  from  within  the
systematic reviews. On the other hand, these organizations have their own journal
platforms  and  the  journal  publishers  themselves  need  to  engage  in  this  policy
development as well. To avoid a meta-waste, Cochrane Database of Systematic Reviews,
Systematic Reviews journal, World Journal of Meta-Analysis, JBI Database of Systematic
Reviews and Implementation Reports,  and Environmental  Evidence  now have a great
opportunity  to  come together  and  set  the  bars  on  reproducibility  of  systematic
reviews.
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